Albumin is a well known negative acute phase reactant, falling with increased inflammation. The decrease in albumin is one of the most potent risk factors for mortality in patients on dialysis. Increased dietary protein intake has been shown in some studies to increase serum albumin levels but this has not led to changes in long-term outcome. Thus, suggesting that inflammation itself and not the serum albumin level leads to this excess mortality in patients on dialysis.